METABOLIC FATE OF 3-(3-METHYLPHENYL)-5-HYDROXYMETHYL-2-OXAZOLIDINONE (TOLOXATONE) A NEW ANTIDEPRESSANT AGENT, IN MANMALNOE A; STROLIN BENEDETTI M.1979; XENOBIOTICA; GBR; DA. 1979; VOL. 9; NO 5; PP. 281-288; BIBL. 8 REF.Article

CIMOXATONE IS A REVERSIBLE TIGHT-BINDING INHIBITOR OF THE A FORM OF RAT BRAIN MONOAMINE OXIDASEFOWLER CJ; STROLIN BENEDETTI M.1983; JOURNAL OF NEUROCHEMISTRY; ISSN 0022-3042; GBR; DA. 1983; VOL. 40; NO 2; PP. 510-513; BIBL. 13 REF.Article

CHARACTERISTICS OF THE INHIBITION OF RAT BRAIN MONOAMINE OXIDASE IN VITRO BY MD 780515KAN JP; STROLIN BENEDETTI M.1981; J. NEUROCHEM.; ISSN 0022-3042; GBR; DA. 1981; VOL. 36; NO 4; PP. 1561-1571; BIBL. 30 REF.Article

ANTAGONISM BETWEEN LONG ACTING MONOAMINE OXIDASE INHIBITORS (MAOI) AND MD 780515, A NEW SPECIFIC AND REVERSIBLE MAOIKAN JP; STROLIN BENEDETTI M.1980; LIFE SCI.; GBR; DA. 1980; VOL. 26; NO 25; PP. 2165-2171; BIBL. 30 REF.Article

NIAPRAZINE, A SELECTIVE BRAIN CATECHOLAMINE DEPLETORKEANE PE; STROLIN BENEDETTI M.1979; NEUROPHARMACOLOGY; GBR; DA. 1979; VOL. 18; NO 7; PP. 595-600; BIBL. 29 REF.Article

MONOAMINE OXIDASE INHIBITORS AND HISTAMINE METABOLISMSTROLIN BENEDETTI M; ANCHER JF; SONTAG N et al.1980; EXPERIENTIA; CHE; DA. 1980; VOL. 36; NO 7; PP. 818-820; BIBL. 34 REF.Article

THE EFFECT OF MONOAMINE OXIDASE A AND B INHIBITORS ON RAT SERUM PROLACTINKEANE PE; MENAGER J; STROLIN BENEDETTI M et al.1981; NEUROPHARMACOLOGY; ISSN 0028-3908; GBR; DA. 1981; VOL. 20; NO 12; PART. A; PP. 1157-1162; BIBL. 43 REF.Article

ABSORPTION, METABOLISM AND EXCRETION OF SAFROLE IN THE RAT AND MAN.STROLIN BENEDETTI M; MALNOE A; BROILLET AL et al.1977; TOXICOLOGY; NETHERL.; DA. 1977; VOL. 7; NO 1; PP. 69-83; BIBL. 7 REF.Article

A COMPARATIVE STUDY OF THE EFFECT OF ORAL CONTRACEPTIVES AND CIGARETTE SMOKING ON PLATELET ADHESIVENESSSTROLIN BENEDETTI M; GUTTY D; STROLIN P et al.1976; HAEMOSTASIS; SWITZ.; DA. 1976; VOL. 5; NO 1; PP. 14-20; BIBL. 25 REF.Article

INTERACTION OF DIFTALONE AND SOME OF ITS METABOLITES WITH HUMAN SERUM PROTEINS. = INTERACTION DE LA DIFTALONE ET DE CERTAINS DE SES METABOLITES, AVEC LES PROTEINES DU SERUM HUMAINASSANDRI A; ZERIAL A; STROLIN BENEDETTI M et al.1975; BIOCHEM. PHARMACOL.; G.B.; DA. 1975; VOL. 24; NO 19; PP. 1767-1770; BIBL. 8 REF.Article

Monoamine oxidase : from physiology and pathophysiology to the design and clinical application of reversible inhibitorsSTROLIN BENEDETTI, M; DOSTERT, P.Advances in Drug Research. 1992, Vol 23, pp 65-125, issn 0065-2490Article

Mécanismes biochimiques de l'hépatotoxicité des psychotropes = Biochemical mechanisms of the psychotropic drugs hepatotoxicityDOSTERT, P; STROLIN BENEDETTI, M.L' Encéphale (Paris). 1984, Vol 10, Num 5, pp 199-209, issn 0013-7006Article

ABSORPTION, DISTRIBUTION, ELIMINATION AND METABOLISM OF ¹⁴C-HEPTAMINOL-HYDROCHLORIDE IN RATCHANOINE F; STROLIN BENEDETTI M; ANCHER JF et al.1981; ARZNEIM.-FORSCH.; ISSN 0004-4172; DEU; DA. 1981; VOL. 31; NO 9; PP. 1430-1435; ABS. GER; BIBL. 26 REF.Article

PRESENCE D'UN ISOTOPE RADIOACTIF DANS LE RUBIDIUM, ANTIDEPRESSEUR POTENTIEL ACTUELLEMENT EN ESSAI THERAPEUTIQUESTROLIN BENEDETTI M; FAURE G; RAYNAUD G et al.1979; NOUV. PRESSE MED.; FRA; DA. 1979; VOL. 8; NO 7; PP. 529; ABS. ENG; BIBL. 5 REF.Article

Drug metabolism and disposition in childrenSTROLIN BENEDETTI, M; BALTES, E. L.Fundamental & clinical pharmacology. 2003, Vol 17, Num 3, pp 281-299, issn 0767-3981, 19 p.Article

Effect of L-dopa, oxyferriscorbone and ferrous iron on in vivo lipid peroxidationDOSTERT, P; STROLIN BENEDETTI, M; FRIGERIO, E et al.Journal of neural transmission. 1991, Vol 84, Num 1-2, pp 119-128, issn 0300-9564, 10 p.Article

Species differences in in vitro hydrolysis of fenofibrate by plasma and intestinal esterasesMAINGUY, Y; VIDAL, R; STROLIN BENEDETTI, M et al.Journal de pharmacie clinique (Paris). 1985, Vol 4, pp 59-70, issn 0291-1981, h. sér. 1Article

High affinity binding site for (+) amphetamine in rat hypothalamus: fact or artefact?LESAGE, A; STROLIN BENEDETTI, M; RUMIGNY, J. F et al.Neurochemistry international. 1984, Vol 6, Num 2, pp 283-286, issn 0197-0186Article

Excretion balance and urinary metabolites of the S-enantiomer of indobufen in rats and miceGRUBB, N; CALDWELL, J; STROLIN-BENEDETTI, M et al.Biochemical pharmacology. 1993, Vol 46, Num 8, pp 1507-1510, issn 0006-2952Article

The metabolism and disposition of ¹⁴C-fenofibrate in human volunteersWEIL, A; CALDWELL, J; STROLIN-BENEDETTI, M et al.Drug metabolism and disposition. 1990, Vol 18, Num 1, pp 115-120, issn 0090-9556Article

The metabolism and disposition of fenofibrate in rta, guinea pig, and dogWEIL, A; CALDWELL, J; STROLIN-BENEDETTI, M et al.Drug metabolism and disposition. 1988, Vol 16, Num 2, pp 302-309, issn 0090-9556Article

Investigation on central dopaminergic receptors (D-2) using the antagonistic properties of new benzamidesRUMIGNY, J.-F; STROLIN BENEDETTI, M; DOSTERT, P et al.Journal of pharmacy and pharmacology. 1984, Vol 36, Num 6, pp 373-377, issn 0022-3573Article

Estimation of the elimination half-life of the monoamine oxidase inhibitor cimoxatone in rat brain on the basis of ex vivo inhibition dataFOWLER, C. J; STROLIN BENEDETTI, M; ROVEI, V et al.European journal of drug metabolism and pharmacokinetics. 1983, Vol 8, Num 4, pp 389-393, issn 0378-7966Article

Determination of 3'-deamino-3'-[2(S)-methody-4-morpholinyl]doxorubicin, a new morpholinyl anthracycline, in plasma by high-performance liquid chromatography with fluorescence detectionBREDA, M; PIANEZZOLA, E; STROLIN BENEDETTI, M et al.Journal of chromatography. Biomedical applications. 1992, Vol 578, Num 2, pp 309-315, issn 0378-4347Article

Animal pharmacokinetics and interspecies scaling of FCE 22101, a penem antibioticEFTHYMIOPOULOS, C; BATTAGLIA, R; STROLIN BENEDETTI, M et al.Journal of antimicrobial chemotherapy (Print). 1991, Vol 27, Num 4, pp 517-526, issn 0305-7453Article